These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8978274)

  • 1. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion.
    Jackow CM; Cather JC; Hearne V; Asano AT; Musser JM; Duvic M
    Blood; 1997 Jan; 89(1):32-40. PubMed ID: 8978274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vbeta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes.
    Davison S; Allen M; Vaughan R; Barker J
    Clin Exp Immunol; 2000 Aug; 121(2):181-6. PubMed ID: 10931129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins.
    Tokura Y; Heald PW; Yan SL; Edelson RL
    J Invest Dermatol; 1992 Jan; 98(1):33-7. PubMed ID: 1728639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients.
    Emge DA; Bassett RL; Duvic M; Huen AO
    Arch Dermatol Res; 2020 May; 312(4):283-288. PubMed ID: 31776647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci.
    Abdelnour A; Bremell T; Holmdahl R; Tarkowski A
    Eur J Immunol; 1994 May; 24(5):1161-6. PubMed ID: 8181526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V beta 11+ T-lymphocyte expansion by toxic shock syndrome toxin-1 differs in mice bearing H-2q versus H-2b haplotypes.
    Zhao YX; Brunsberg U; Holmdahl R; Tarkowski A
    Immunology; 1998 May; 94(1):1-4. PubMed ID: 9708179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus superantigens elicit redundant and extensive human Vbeta patterns.
    Thomas D; Dauwalder O; Brun V; Badiou C; Ferry T; Etienne J; Vandenesch F; Lina G
    Infect Immun; 2009 May; 77(5):2043-50. PubMed ID: 19255190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen.
    Koyama A; Kobayashi M; Yamaguchi N; Yamagata K; Takano K; Nakajima M; Irie F; Goto M; Igarashi M; Iitsuka T
    Kidney Int; 1995 Jan; 47(1):207-16. PubMed ID: 7731148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus Isolated from Skin from Atopic-Dermatitis Patients Produces Staphylococcal Enterotoxin Y, Which Predominantly Induces T-Cell Receptor Vα-Specific Expansion of T Cells.
    Aziz F; Hisatsune J; Yu L; Kajimura J; Sato'o Y; Ono HK; Masuda K; Yamaoka M; Salasia SIO; Nakane A; Ohge H; Kusunoki Y; Sugai M
    Infect Immun; 2020 Jan; 88(2):. PubMed ID: 31740530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative real time PCR method to analyze T cell receptor Vbeta subgroup expansion by staphylococcal superantigens.
    Seo KS; Park JY; Terman DS; Bohach GA
    J Transl Med; 2010 Jan; 8():2. PubMed ID: 20070903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis.
    Schlievert PM; Case LC; Strandberg KL; Abrams BB; Leung DY
    Clin Infect Dis; 2008 May; 46(10):1562-7. PubMed ID: 18419342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis.
    Bunikowski R; Mielke ME; Skarabis H; Worm M; Anagnostopoulos I; Kolde G; Wahn U; Renz H
    J Allergy Clin Immunol; 2000 Apr; 105(4):814-9. PubMed ID: 10756234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
    J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous colonization with staphylococci influences the disease activity of Sézary syndrome: a potential role for bacterial superantigens.
    Tokura Y; Yagi H; Ohshima A; Kurokawa S; Wakita H; Yokote R; Shirahama S; Furukawa F; Takigawa M
    Br J Dermatol; 1995 Jul; 133(1):6-12. PubMed ID: 7669641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to toxic-shock-syndrome toxin-1 (TSST-1) and to staphylococcal enterotoxins A, B and C in Staphylococcus aureus infections.
    Kunstmann G; Schröder E; Hasbach H; Pulverer G
    Zentralbl Bakteriol; 1989 Oct; 271(4):486-92. PubMed ID: 2818798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
    Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
    Lane P; Haller C; McConnell F
    Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and clonal expansion of human myelin basic protein-reactive T cells by bacterial superantigens.
    Zhang J; Vandevyver C; Stinissen P; Mertens N; van den Berg-Loonen E; Raus J
    J Autoimmun; 1995 Aug; 8(4):615-32. PubMed ID: 7492354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
    Lussow AR; MacDonald HR
    Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.